Literature DB >> 10468764

Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography.

P Ulleryd1, B Zackrisson, G Aus, S Bergdahl, J Hugosson, T Sandberg.   

Abstract

OBJECTIVE: To determine the frequency of prostatic involvement in men with community-acquired febrile urinary tract infection. PATIENTS AND METHODS: This prospective study included 70 men (18-85 years old) who had a fever of >/=38.0 degrees C, symptoms or signs of urinary tract infection and a positive urine culture. Serum prostate-specific antigen (PSA) was measured and transrectal ultrasonography of the prostate and seminal vesicles performed during the acute phase of the disease and during a 1-year follow-up.
RESULTS: Although only six patients had a tender prostate on digital rectal examination, the initial serum PSA level was elevated in 58 (83%) patients (median 14 ng/mL, range 0.54-140). There was no correlation between PSA levels, patient age, inflammatory response to infection or presence of positive blood cultures. Despite a rapid decline in PSA level after one month, there was a protracted decrease in some patients. After 3 months the median prostate volume was reduced by 31% (range 11-54; P<0.001) in 46 of 55 patients examined, and the width of the right and left seminal vesicle was reduced by 14% and 22%, respectively. The reductions in PSA and prostate volume were significantly correlated (r=0.36, 95% confidence interval 0.09-0.58; P=0.01).
CONCLUSION: These results show that the prostate and seminal vesicles are frequently involved in men with febrile urinary tract infection and that PSA may be a useful marker of prostatic infection. The slow decline of PSA levels in some patients after appropriate antibiotic treatment indicates a protracted healing process and should be considered when PSA is used to detect prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468764     DOI: 10.1046/j.1464-410x.1999.00164.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  20 in total

1.  Blood cultures for men with febrile urinary tract infection.

Authors:  Alex Smithson; Cristina Chico; Maria Sanchez; Cristina Netto; Maria Teresa Bastida; Manuel Etienne; François Caron
Journal:  J Clin Microbiol       Date:  2010-07       Impact factor: 5.948

2.  Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection.

Authors:  James R Johnson; Flemming Scheutz; Peter Ulleryd; Michael A Kuskowski; Timothy T O'Bryan; Torsten Sandberg
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Fluoroquinolone Antimicrobial Agents in the Treatment of Prostatitis and Recurrent Urinary Tract Infections in Men.

Authors:  F M E Wagenlehner; K G Naber
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

4.  Acquisition of a pathogenicity island in an Escherichia coli clinical isolate causing febrile urinary tract infection.

Authors:  S M Soto; S Zúñiga; P Ulleryd; J Vila
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-18       Impact factor: 3.267

Review 5.  Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

Authors:  David Ulmert; M Frank O'Brien; Anders S Bjartell; Hans Lilja
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

6.  Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-up.

Authors:  Marvin E Langston; Ratna Pakpahan; Remington L Nevin; Angelo M De Marzo; Debra J Elliott; Charlotte A Gaydos; William B Isaacs; William G Nelson; Lori J Sokoll; Jonathan M Zenilman; Elizabeth A Platz; Siobhan Sutcliffe
Journal:  Prostate       Date:  2018-05-30       Impact factor: 4.104

7.  In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors.

Authors:  Andreas Reisner; Karen A Krogfelt; Bjarke M Klein; Ellen L Zechner; Søren Molin
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

8.  Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity.

Authors:  Amit M Algotar; Patricia A Thompson; James Ranger-Moore; M Suzanne Stratton; Chiu-Hsieh Hsu; Frederick R Ahmann; Raymond B Nagle; Steven P Stratton
Journal:  Prostate       Date:  2010-06-01       Impact factor: 4.104

9.  Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study.

Authors:  Ahmed S Safwat; Ahmad Hasanain; Ahmed Shahat; Mostafa AbdelRazek; Hazem Orabi; Samir K Abdul Hamid; Amany Nafee; Sally Bakkar; Mohamed Sayed
Journal:  World J Urol       Date:  2018-10-25       Impact factor: 4.226

10.  Antimicrobial Resistance Patterns and Dynamics of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli in Cusco, Peru.

Authors:  Steev Loyola; Fátima Concha-Velasco; Jimena Pino-Dueñas; Nancy Vasquez-Luna; Paola Juarez; Carlos Llanos; Guillermo Salvatierra; Jesus Tamariz; Andres G Lescano
Journal:  Antibiotics (Basel)       Date:  2021-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.